TIORMAX Trademark

Trademark Overview

On Wednesday, September 29, 2004, a trademark application was filed for TIORMAX with the United States Patent and Trademark Office. The USPTO has given the TIORMAX trademark a serial number of 79006453. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, July 3, 2014. This trademark is owned by BIOPROJET PHARMA. The TIORMAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for treatment of diarrhoea in adults and children for the treatment of viral and infectious diseases, medicines for human purposes, namely medicines for the treatment of gastrointestinal diseases; biological preparations for medical or veterinary purposes, sedatives, clinical-pharmaceutical products for the treatment of gastrointestinal diseases; chemical preparations for medical or veterinary use, dietetic foods adapted for medical use
tiormax

General Information

Serial Number79006453
Word MarkTIORMAX
Filing DateWednesday, September 29, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, July 3, 2014
Registration Number3120855
Registration DateTuesday, July 25, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2006

Trademark Statements

Goods and ServicesPharmaceutical products for treatment of diarrhoea in adults and children for the treatment of viral and infectious diseases, medicines for human purposes, namely medicines for the treatment of gastrointestinal diseases; biological preparations for medical or veterinary purposes, sedatives, clinical-pharmaceutical products for the treatment of gastrointestinal diseases; chemical preparations for medical or veterinary use, dietetic foods adapted for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 6, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOPROJET PHARMA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameBIOPROJET PHARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameBIOPROJET PHARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Monday, June 1, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, January 15, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, January 15, 2015DEATH OF INTERNATIONAL REGISTRATION
Thursday, August 14, 2014TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, May 6, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 6, 2013CANCELLED SECTION 71
Wednesday, February 13, 2013REVIEW OF CORRESPONDENCE COMPLETE - SEE NOTE TO FILE
Thursday, August 9, 2012POST REGISTRATION ACTION MAILED - SEC.71
Wednesday, August 8, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 25, 2012TEAS SECTION 71 RECEIVED
Friday, April 18, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, March 25, 2007FINAL DISPOSITION NOTICE SENT TO IB
Sunday, March 25, 2007FINAL DISPOSITION PROCESSED
Friday, March 23, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 25, 2006REGISTERED-PRINCIPAL REGISTER
Thursday, May 18, 2006NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, May 4, 2006NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, May 4, 2006NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, May 2, 2006PUBLISHED FOR OPPOSITION
Thursday, April 20, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 12, 2006NOTICE OF PUBLICATION
Saturday, March 11, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 24, 2006ASSIGNED TO LIE
Tuesday, February 21, 2006EXAMINERS AMENDMENT MAILED
Friday, February 17, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 17, 2006EXAMINER'S AMENDMENT ENTERED
Friday, February 17, 2006EXAMINERS AMENDMENT -WRITTEN
Thursday, February 16, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 16, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 16, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 16, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 23, 2006FINAL REFUSAL MAILED
Saturday, January 21, 2006FINAL REFUSAL WRITTEN
Tuesday, January 17, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 10, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 9, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 9, 2006PETITION TO REVIVE-GRANTED
Monday, January 9, 2006TEAS PETITION TO REVIVE RECEIVED
Tuesday, December 13, 2005ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, December 13, 2005ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 7, 2005REFUSAL PROCESSED BY IB
Monday, May 16, 2005NON-FINAL ACTION MAILED
Thursday, May 12, 2005NON-FINAL ACTION WRITTEN
Thursday, May 12, 2005NEW REPRESENTATIVE AT IB RECEIVED
Thursday, April 28, 2005ASSIGNED TO EXAMINER
Friday, December 3, 2004NEW APPLICATION ENTERED IN TRAM
Thursday, December 2, 2004SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

tiormax treatment diseases medical medicines pharmaceutical gastrointestinal preparations veterinary purposes products